Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryo-Thermal Ablation + Toripalimab + Chemotherapy as Neoadjuvant for Resectable Stage IB-IIIB NSCLC
NCT07855965Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in non-small cell lung cancer (NSCLC), sponsored by West China Hospital of Sichuan University. Started Sep 2026; status: recruiting.
02
Drugs
toripalimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07855965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07855965.